SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-069457
Filing Date
2020-06-03
Accepted
2020-06-03 16:30:50
Documents
1
Effectiveness Date
2020-06-03

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2021708d1_defa14a.htm DEFA14A 27494
  Complete submission text file 0001104659-20-069457.txt   28823
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33958 | Film No.: 20940423
SIC: 2834 Pharmaceutical Preparations